BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 12621480)

  • 1. Cerebral Infectious Opportunistic Lesions in a Patient with Acute Myeloid Leukaemia: The Challenge of Diagnosis and Clinical Management.
    Cavazza G; Motto C; Regna-Gladin C; Travi G; Di Gennaro E; Peracchi F; Monti B; Corti N; Greco R; Minga P; Riva M; Rimoldi S; Vecchi M; Rogati C; Motta D; Pazzi A; Vismara C; Bandiera L; Crippa F; Mancini V; Sessa M; Oltolini C; Cairoli R; Puoti M
    Antibiotics (Basel); 2024 Apr; 13(5):. PubMed ID: 38786116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying genetic susceptibility to Aspergillus fumigatus infection using collaborative cross mice and RNA-Seq approach.
    Yosief RHS; Lone IM; Nachshon A; Himmelbauer H; Gat-Viks I; Iraqi FA
    Animal Model Exp Med; 2024 Feb; 7(1):36-47. PubMed ID: 38356021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracerebral opportunistic infections caused by immunosuppressants after orthotopic liver transplantation: Report of two cases and literature review.
    Guo Y; Zhu Z; Cai W; Tao S; Yin D
    Front Immunol; 2022; 13():1003254. PubMed ID: 36544772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Systematic Review to Assess the Relationship between Disseminated Cerebral Aspergillosis, Leukemias and Lymphomas, and Their Respective Therapeutics.
    Sullivan BN; Baggett MA; O'Connell SS; Pickett KM; Steele C
    J Fungi (Basel); 2022 Jul; 8(7):. PubMed ID: 35887477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caspofungin Cerebral Penetration and Therapeutic Efficacy in Experimental Cerebral Aspergillosis.
    Ullmann I; Aregger A; Leib SL; Zimmerli S
    Microbiol Spectr; 2022 Jun; 10(3):e0275321. PubMed ID: 35435756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [BK virus encephalitis in children with hematopoietic stem cell transplantation].
    Li N; Huang XJ; Wang Y; Suo P; Xu LP; Liu KY; Zhang XH; Yan CH; Wang FR; Kong J; Cheng YF
    Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):823-827. PubMed ID: 34788921
    [No Abstract]   [Full Text] [Related]  

  • 7. Fungal brain infection-no longer a death sentence.
    Lange N; Wantia N; Jörger AK; Wagner A; Liesche F; Meyer B; Gempt J
    Neurosurg Rev; 2021 Aug; 44(4):2239-2244. PubMed ID: 33037537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral and pulmonary aspergillosis, treatment and diagnostic challenges of mixed breakthrough invasive fungal infections: case report study.
    Amanati A; Lotfi M; Masoudi MS; Jafarian H; Ghasemi F; Bozorgi H; Badiee P
    BMC Infect Dis; 2020 Jul; 20(1):535. PubMed ID: 32703183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact.
    Dowling MR; Li S; Dey BR; McAfee SL; Hock HR; Spitzer TR; Chen YB; Ballen KK
    Bone Marrow Transplant; 2018 Feb; 53(2):199-206. PubMed ID: 29131150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Performance of Galactomannan Antigen Testing in Cerebrospinal Fluid.
    Chong GM; Maertens JA; Lagrou K; Driessen GJ; Cornelissen JJ; Rijnders BJ
    J Clin Microbiol; 2016 Feb; 54(2):428-31. PubMed ID: 26659218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunistic infections of the central nervous system in the transplant patient.
    Cohen BA; Stosor V
    Curr Neurol Neurosci Rep; 2013 Sep; 13(9):376. PubMed ID: 23881624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNS aspergillosis: recognition, diagnosis and management.
    Ruhnke M; Kofla G; Otto K; Schwartz S
    CNS Drugs; 2007; 21(8):659-76. PubMed ID: 17630818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspergillosis of the central nervous system: a catastrophic opportunistic infection.
    Pongbhaesaj P; Dejthevaporn C; Tunlayadechanont S; Witoonpanich R; Sungkanuparph S; Vibhagool A
    Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):119-25. PubMed ID: 15272754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients.
    Jantunen E; Piilonen A; Volin L; Parkkali T; Koukila-Kähkölä P; Ruutu T; Ruutu P
    Bone Marrow Transplant; 2000 Apr; 25(8):867-71. PubMed ID: 10808208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low incidence of invasive aspergillosis in allogeneic stem cell transplant recipients receiving amphotericin B inhalation prophylaxis.
    Nihtinen A; Anttila VJ; Ruutu T; Juvonen E; Volin L
    Transpl Infect Dis; 2012 Feb; 14(1):24-32. PubMed ID: 21749589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress?
    Jantunen E; Anttila VJ; Ruutu T
    Bone Marrow Transplant; 2002 Dec; 30(12):925-9. PubMed ID: 12476286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous system aspergillosis in allogeneic stem cell transplant recipients.
    Jantunen E; Volin L; Salonen O; Piilonen A; Parkkali T; Anttila VJ; Paetau A; Ruutu T
    Bone Marrow Transplant; 2003 Feb; 31(3):191-6. PubMed ID: 12621480
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.